Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
Article in Nature Reviews Clinical Oncology (April 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Article in Nature Reviews Clinical Oncology (April 2024)
Article in Med (April 2023)
Article in Journal of Cancer Policy (January 2023)